dose switching from semaglutide to tirzepatide "Reducing frequency does not commensurately reduce weight loss. For example, merely one dose per week (q1wk) one dose every 2 weeks (q2wk) maintains roughly 75% of the weight transitioning from semaglutide to tirzepatide

Here's how AOD 9604 compares: AOD 9604 vs HGH Fragment 176-191 They're virtually identical

It has no negative effect on weight, and many patients experience modest weight loss

10 Another study assessing the presence of GLP-1Rs in cultured keratinocytes demonstrated that GLP-1R mRNA was present and Western blot confirmed protein expression of GLP-1Rs

These studies indicate an increased risk for serious, potentially life-altering conditions such as gastroparesis, blood clots, and vision loss associated with the use of the drug

For others, the changes might be more gradual, becoming apparent only after six months to a year of sustained weight loss